For mRNA, Covid Vaccines Are Just the Beginning – WIRED
One of mRNA’s strengths is its “remarkable agility,” as Hatchett puts it. Its only raw ingredients are the four nucleotides...
News
/cloudfront-us-east-2.images.arcpublishing.com/reuters/OC6EZKJILZKTPM6WHJS567HBCU.jpg)
The case for testing Pfizer’s Paxlovid for treating long COVID – Reuters
SummaryCompaniesTwo long COVID patients recover after Paxlovid treatmentSide effects, safety issues need to be studiedCHICAGO, April 18 (Reuters) - Reports...
What It’ll Take to Have Actually Good COVID Summers – The Atlantic
Almost exactly 12 months ago, America’s pandemic curve hit a pivot point. Case counts peaked—and then dipped, and dipped, and...
Covid-19 Boosters — Where from Here? | NEJM – nejm.org
On December 10, 2020, Pfizer presented results from a 36,000-person, two-dose, prospective, placebo-controlled trial of its Covid-19 messenger RNA (mRNA)...
The Grief of 1 Million COVID Deaths Is Not Going Away – The Atlantic
Lucy Esparza-Casarez thinks she caught the coronavirus while working the polls during California’s 2020 primary election, before bringing it home...
How accurate are COVID-19 rapid antigen tests, and when is the best time to use them? – ABC News
Rapid antigen tests, better known as RATs, have become an important tool in Australia's arsenal against COVID-19.While PCR tests are...
Having Covid Can Be Confusing. Here’s What to Expect – The New York Times
Having Covid can be a wildly confusing experience. But you can still make a plan to get through the course...
Is it COVID or a cold? How to know as Omicron cases rise – CBC News
This story idea came from audience members, like you, who got in touch with us. Send us all of your...
Public anger mounts in locked-down Shanghai with no end in sight. Here’s what you need to know – CNN
Hong Kong CNN — Millions of people across China’s locked-down financial hub of Shanghai have been desperately seeking medical care...
Why So Many COVID Predictions Were Wrong – The Atlantic
Updated at 12:13 p.m. ET on April 7, 2022.As many prominent policy makers reckon uncomfortably with persistent inflation after months...